media – Page 522 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Bristol-Myers Squibb Announces Worldwide Collaboration with Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy

Factor XIa inhibitor moving into Phase 2 Trials for Secondary Stroke Prevention Bristol-Myers Squibb to receive upfront payment and companies to share development and commercialization costs, and global profits
- Source: news.bms
- 606
- April 23, 2018
Bristol-Myers Squibb Cardiovascular Therapy Janssen
Merck KGaA, not Pfizer, lands consumer health deal with P&G worth $4.2B

Merck KGaA will hand P&G a consumer business that has grown 6% over the past two years. (Merck KGaA) Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.
- Source: fiercepharma
- 3,302
- April 23, 2018
Company Insight consumer business Merck
Is mHealth Monitoring for Hypertension Safer Than the Doctor’s Office?

A recent study of so-called 'white coat hypertension' finds that blood pressure readings taken at the doctor's office can be less accurate and more dangerous than readings taken at home with mHealth devices.
- Source: mHealthIntelligence
- 1,270
- April 23, 2018
hypertension mHealth Researches
RapidSOS collects $16M to deliver stronger data to emergency response teams

RapidSOS, a five-year-old startup focused on updating emergency response systems with data-driven technology, has raised $16 million in funding from Highland Capital, Microsoft Ventures, and CSAA Insurance Group, according to a statement. Forté Ventures also contributed.
- Source: MobiHealthNews
- 463
- April 23, 2018
Company Insights digital health healthcare
The 3 most valuable applications of AI in health care

A recent report from Accenture analyzed the “near-term value” of AI applications in health care to determine how the potential impact of the technology stacks up against the upfront costs of implementation. Results from the report estimated that AI applications in health care could save up to $150 billion annually for the U.S. health care economy by 2026.
- Source: Venture Beats
- 699
- April 23, 2018
AI digital health Market Views
Amid tough respiratory competition, AstraZeneca inks Symbicort outcomes-based deals

It's no secret that respiratory drugs make up a crowded field, and forthcoming generics will make the competition tougher still. AstraZeneca's Symbicort is no stranger to the fallout, either, what with payers pressing prices and new rivals grabbing share.
- Source: fiercepharma
- 632
- April 20, 2018
AstraZeneca Company Insights Symbicor
BenevolentAI raises $115 million to extend its leading global position in the field of AI enabled drug development

BenevolentAI today announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the largest funding rounds in the AI pharmaceutical sector.
- Source: benevolent.ai
- 564
- April 20, 2018
AI Company Insight
Amgen Presents First-Of-Its-Kind Data At AAN Annual Meeting Reinforcing Robust And Consistent Efficacy Of Aimovig™ (erenumab) For Migraine Patients With Multiple Treatment Failures

The LIBERTY Trial was Conducted in Patients who Have Tried Two to Four Therapies Without Success -- a Uniquely Difficult-to-Treat Population Often Excluded From Migraine Prevention Trials Patients Taking Aimovig had Nearly Three-Fold Higher Odds of Having Their Migraine Days cut by Half or More Compared to Placebo Safety and Tolerability Were Consistent With Results Seen in the Pivotal Clinical Program; Over 97 Percent of Those Taking Aimovig Completed the Double-Blind Treatment Phase Data Selected by the American Academy of Neurology Science Committee as one of the Most Noteworthy Presentations at 2018 Annual Meeting
- Source: prnewswire
- 637
- April 20, 2018
Amgen migraine
Hanmi Pharma gives up on development of lung cancer drug Olita

South Korean pharmaceutical firm Hanmi Pharmaceutical is expected to cease development of Olita, a lung cancer treatment, following its slow progress in clinical trials and cancellation of licensing deals with foreign drug makers.
- Source: koreaher
- 2,357
- April 20, 2018
Clinical Trials Company Insights Olita
FDA’s 2019 budget request cites digital health; agency rolls out medical device initiative

Digital health appears to be making its way onto the national stage. On Tuesday, FDA Commissioner Scott Gottlieb gave the field a shout-out in his remarks to the US House Subcommittee on Agriculture, Rural Development concerning the Fiscal Year 2019 budget request for the FDA.
- Source: MobiHealthNews
- 635
- April 20, 2018
digital health FDA

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.